Cargando…
Methodological challenges and biases in the field of cognitive function among patients with chronic kidney disease
Chronic kidney disease (CKD) affects approximately 850 million people globally and is associated with an increased risk of cognitive impairment. The prevalence of cognitive impairment among CKD patients ranges from 30 to 60%, and the link between CKD and cognitive impairment is partially understood....
Autores principales: | Giannakou, Konstantinos, Golenia, Aleksandra, Liabeuf, Sophie, Malyszko, Jolanta, Mattace-Raso, Francesco, Farinha, Ana, Spasovski, Goce, Hafez, Gaye, Wiecek, Andrzej, Capolongo, Giovanna, Capasso, Giovambattista, Massy, Ziad A., Pépin, Marion |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446481/ https://www.ncbi.nlm.nih.gov/pubmed/37621458 http://dx.doi.org/10.3389/fmed.2023.1215583 |
Ejemplares similares
-
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients
por: Hafez, Gaye, et al.
Publicado: (2023) -
Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor
por: Liabeuf, Sophie, et al.
Publicado: (2023) -
Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
por: Liabeuf, Sophie, et al.
Publicado: (2021) -
The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council
por: Zoccali, Carmine, et al.
Publicado: (2018) -
Phosphate in the Context of Cognitive Impairment and Other Neurological Disorders Occurrence in Chronic Kidney Disease
por: Rroji, Merita, et al.
Publicado: (2022)